Dog-Assisted Therapy vs Relaxation for Children and Adolescents with Fetal Alcohol Spectrum Disorder: A Randomized Controlled Study.
Saved in:
| Title: | Dog-Assisted Therapy vs Relaxation for Children and Adolescents with Fetal Alcohol Spectrum Disorder: A Randomized Controlled Study. |
|---|---|
| Authors: | Vidal, Raquel (AUTHOR), Vidal, Laura (AUTHOR), Lugo, Jorge (AUTHOR), Ristol, Francesc (AUTHOR), Domènec, Eva (AUTHOR), Casas, Teresa (AUTHOR), Veiga, Anna (AUTHOR), Vico, Cristina (AUTHOR), Ramos-Quiroga, Josep Antoni (AUTHOR), Gómez-Barros, Nuria (AUTHOR) |
| Source: | Journal of Autism & Developmental Disorders. Aug2024, Vol. 54 Issue 8, p3133-3141. 9p. |
| Subjects: | Pet therapy, Autonomy (Psychology), T-test (Statistics), Statistical significance, Research funding, Statistical sampling, Treatment effectiveness, Randomized controlled trials, Chi-squared test, Descriptive statistics, Fetal alcohol syndrome, Quality of life, Data analysis software, Relaxation techniques, Adolescence |
| Abstract: | The rationale of this study was to evaluate the efficacy of Dog-assisted Therapy (DAT) in children and adolescents with Fetal Alcohol Spectrum Disorder (FASD). We conducted a randomized controlled trial in a cohort of 71 children and adolescents with FASD. Participants were randomly assigned either to DAT group (n = 38) or Relaxation Group (control group) (n = 33). Results revealed that participants who were assigned to the DAT group experienced significantly reduced externalizing symptoms (CBCL Externalizing Inattention: t (69) = 2.81, p =.007; d = 0.7); CBCL Opposition: t (69) = 2.54, p =.013; d = 0.6), reduced internalizing symptoms (CBCL Social problems: t (69) = 3.21, p =.002; d = 0.8) as well as improvements on social skills (SSIS-P Problem behavior: t (68) = 2.55, p =.013; d = 0.6), and quality of life (KidScreen Autonomy and Parents: t (51) = − 2.03, p =.047; d = 0.5) compared to the relaxation control group. The relaxation control group obtained significant differences between the pre- and post-treatment evaluation, diminishing withdraw symptoms (t (32) = 3.03, p =.005; d = 0.2). Results suggest that DAT and relaxation may be promising adjunctive treatments for children and adolescents with FASD. Clinical trial registration information:http://clinicaltrials.gov/; NCT04038164. [ABSTRACT FROM AUTHOR] |
| Copyright of Journal of Autism & Developmental Disorders is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | The rationale of this study was to evaluate the efficacy of Dog-assisted Therapy (DAT) in children and adolescents with Fetal Alcohol Spectrum Disorder (FASD). We conducted a randomized controlled trial in a cohort of 71 children and adolescents with FASD. Participants were randomly assigned either to DAT group (n = 38) or Relaxation Group (control group) (n = 33). Results revealed that participants who were assigned to the DAT group experienced significantly reduced externalizing symptoms (CBCL Externalizing Inattention: t (69) = 2.81, p =.007; d = 0.7); CBCL Opposition: t (69) = 2.54, p =.013; d = 0.6), reduced internalizing symptoms (CBCL Social problems: t (69) = 3.21, p =.002; d = 0.8) as well as improvements on social skills (SSIS-P Problem behavior: t (68) = 2.55, p =.013; d = 0.6), and quality of life (KidScreen Autonomy and Parents: t (51) = − 2.03, p =.047; d = 0.5) compared to the relaxation control group. The relaxation control group obtained significant differences between the pre- and post-treatment evaluation, diminishing withdraw symptoms (t (32) = 3.03, p =.005; d = 0.2). Results suggest that DAT and relaxation may be promising adjunctive treatments for children and adolescents with FASD. Clinical trial registration information:http://clinicaltrials.gov/; NCT04038164. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 01623257 |
| DOI: | 10.1007/s10803-023-06023-5 |
